Global Trials
The ISN-ACT Global Trials Focus team has collected and published a new list of randomized research from nephrologists around the world for August 2020.
![Global-Trials Global-Trials](https://www.theisn.org/wp-content/uploads/2020/08/Global-Trials-600x411.jpg)
Each trial is reviewed in context and the risk of bias in seven key areas is assessed.
Highlight:
Allopurinol does not slow the progression of chronic kidney disease in patients with type 1 diabetes.
See the latest trials here.
Would you like to support equal access to nephrology research? Become an ISN Member